Yasunori Kaneko, Director at Arcus Biosciences, Inc. (RCUS), bought 20,000 shares at $10.06 ($201K) on 2025-02-27, disclosed to the SEC on 2025-02-27.
Open-market purchase of $201k RCUS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| PRTO | BUY | 2014-10-29 | $2.0M | — | Filing → |
| PRTO | SELL | 2014-10-29 | $560K | — | Filing → |
| TTPH | BUY | 2013-03-27 | $4.8M | — | Filing → |